Ann Rhoads

Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

Myriad Women's Health, Inc. provides pre-pregnancy genetic testing services. It operates as a medical technology company that gives people access to vital information about their bodies, including DNA analysis for family preparation, and inherited cancers. The firm offers genetic counseling over the phone and gives client direct access to a professional genetics expert who can interpret their report. The company was founded by Ramji Srinivasan, Eric A. Evans, Rishi Kacker and Balaji S. Srinivasan on October 24, 2007 and is headquartered in South San Francisco, CA.

Sprout Group (Sprout) is venture capital subsidiary of Credit Suisse Private Equity LLC founded in 1969. The firm headquartered in New York.

Innovatix LLC provides group purchasing and consulting services. It offers negotiated contract discounts for various product categories, including blood products, capital equipment, enteral nutrition products and equipment, foodservice distribution, supplies and equipment, medical supplies, laboratory services and IT equipment and supplies. The company was founded in 1993 and is headquartered in New York, NY.

The YMCA of Greater Kansas City, a non-profit organization with an inclusive environment committed to enriching the quality of family, spiritual, social, mental and physical well-being. grams. The company is headquartered in Kansas City, MO.

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.

iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.

Alastin Skincare, Inc. develops and markets skin care products that reinvigorate, protect, and maintain healthy skin. It offers skin procedures such as injectables, laser resurfacing, microneedling, peels, photo rejuvination, radio frequency, skin tightening, surgical procedures, and ultra sound therapy. The company was founded by Scott L. Glenn and Cam L. Garner in 2015 and is headquartered in Carlsbad, CA.